Company Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates.
This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications.
The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health.
The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices.
This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops.
It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
| Country | United States |
| Founded | 1967 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 1,361 |
| CEO | Theodore Harris |
Contact Details
Address: 5 Paragon Drive Montvale, New Jersey 07645 United States | |
| Phone | 845 326 5600 |
| Website | balchem.com |
Stock Details
| Ticker Symbol | BCPC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000009326 |
| CUSIP Number | 057665200 |
| ISIN Number | US0576652004 |
| Employer ID | 13-2578432 |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Theodore Lee Harris | Chief Executive Officer, President and Chairman |
| Carl Martin Bengtsson | Executive Vice President, Chief Financial Officer, Treasurer and GM of Animal Nutrition and Health |
| Hatsuki Miyata J.D. | Executive Vice President, Chief Legal Officer and Secretary |
| Martin Luther Reid | Senior Vice President and Chief Supply Chain Officer |
| Frederic Boned | Senior Vice President and GM of Human Nutrition and Health |
| William A. Backus CPA | Vice President and Chief Accounting Officer |
| Jonathan H. Griffin | Senior Vice President of Corporate Development |
| M. Brent Tignor | Senior Vice President and Chief Human Resources Officer |
| Job L. van Gunsteren | Senior Vice President and GM of Specialty Products |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 31, 2025 | 10-Q | Quarterly Report |
| Jul 31, 2025 | 8-K | Current Report |
| Jul 18, 2025 | SCHEDULE 13G/A | Filing |
| Jun 24, 2025 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 20, 2025 | 8-K | Current Report |
| May 14, 2025 | SCHEDULE 13G/A | Filing |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 24, 2025 | 10-Q | Quarterly Report |
| Apr 24, 2025 | 8-K | Current Report |